Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
The present invention provides novel compounds that are capable of
inhibiting mitogen activated protein kinase-activated protein kinase-2
and analogues thereof and pharmaceutical compositions and kits that
include these compounds.